HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heide Wissel Selected Research

Critical Illness (Critically Ill)

11/2009Early subcutaneous administration of etanercept (Enbrel) prevents from hyperoxia-induced lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heide Wissel Research Topics

Disease

2Hyperoxia
11/2009 - 01/2005
1Lung Diseases (Lung Disease)
11/2009
1Pneumonia (Pneumonitis)
11/2009
1Lung Injury
11/2009
1Acute Lung Injury
11/2009
1Critical Illness (Critically Ill)
11/2009
1Bacterial Pneumonia
09/2006
1Inflammation (Inflammations)
03/2005
1Necrosis
01/2005
1Infections
09/2003
1Surfactant Dysfunction
09/2003

Drug/Important Bio-Agent (IBA)

3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009 - 01/2005
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2009 - 01/2005
2Caspase 3 (Caspase-3)IBA
11/2009 - 01/2005
2NF-kappa B (NF-kB)IBA
03/2005 - 01/2005
1Indicators and Reagents (Reagents)IBA
11/2009
1Etanercept (Enbrel)FDA Link
11/2009
1Immunoglobulin G (IgG)IBA
11/2009
1Immunoglobulins (Immunoglobulin)IBA
11/2009
1FluorocarbonsIBA
09/2006
1Caspase 8 (Caspase-8)IBA
01/2005
1CaspasesIBA
01/2005
1Cytochromes c (Cytochrome c)IBA
01/2005
1Caspase 9IBA
01/2005
1Surface-Active Agents (Surfactants)IBA
09/2003
1LipidsIBA
09/2003
1Proteins (Proteins, Gene)FDA Link
09/2003

Therapy/Procedure

1Artificial Respiration (Mechanical Ventilation)
11/2009